Brief: BioArctic Q2 Operating Profit SEK -75.8 Million
29/08/2024 07:01
Aug 29 (Reuters) - BioArctic Q2 net income SEK -68.4 million. * Q2 adjusted EPS SEK -0.77 * Q2 adjusted free cash flow SEK -94.3 million * Q2 revenue SEK 49.8 million
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln